Adel(@adelssane) 's Twitter Profile Photo

So honored to speak at the Day conference. These moments are so emotional! When I started my speech, my heart was beating so fast. I shed a tear when I thought of my daughter 😢 I’m not an expert, I’m only a Dad

So honored to speak at the #RareDiseaseDay conference. These moments are so emotional! When I started my speech, my heart was beating so fast. I shed a tear when I thought of my daughter 😢 I’m not an expert, I’m only a Dad #caregiver #EpilepsyVoices #Dravetsyndrome #RareDisease
account_circle
Adel(@adelssane) 's Twitter Profile Photo

I’ve been invited to share my daughter’s story living with and spectrumdisorders during a regional conference about 😊30% of people with are diagnosed with autism! 💙

I’ve been invited to share my daughter’s story living with #dravetsyndrome and #autismspectrumdisorders during  a regional conference about #autism 😊30% of people with #epilepsy are diagnosed with autism! #EpilepsyVoices #braindisorders #speechdelay #WorldAutismAwarenessDay 💙
account_circle
UCSF Pediatric Brain Center(@UCSF_PBC) 's Twitter Profile Photo

Published in American Epilepsy Society,UCSF Benioff SF' Joseph Sullivan, MD, and Mayo Clinic’s Elaine C. Wirrell, MD, review new antiseizure medications and potential disease-modifying therapies for Dravet Syndrome Foundation UCSFepilepsy journals.sagepub.com/doi/10.1177/15…

account_circle
Bakar Labs(@bakarlabs_uc) 's Twitter Profile Photo

Our latest is out! Learn about Regel Tx's co-founder & CSO @NavneetKMatharu and her mission to help patients suffering from rare diseases using a new approach to : bakarlabs.berkeley.edu/tenant-spotlig…

Our latest #TenantSpotlight is out! Learn about Regel Tx's co-founder & CSO @NavneetKMatharu and her mission to help patients suffering from rare diseases using a new approach to #genetherapy: bakarlabs.berkeley.edu/tenant-spotlig…  #DravetSyndrome
account_circle
Encoded Therapeutics(@EncodedTx) 's Twitter Profile Photo

Encoded announces approval of UK CTA application for clinical study of gene therapy candidate ETX101 for Dravet syndrome. Phase 1/2 clinical trial in the UK is planned to begin in mid-2024. More: ow.ly/hMVB50QHY2P

Encoded announces approval of UK CTA application for clinical study of gene therapy candidate ETX101 for Dravet syndrome. Phase 1/2 clinical trial in the UK is planned to begin in mid-2024. More:  ow.ly/hMVB50QHY2P
#GeneTherapy #DravetSyndrome #ETX101 #POLARIS #EXPEDITION
account_circle
Dravet Syndrome UK(@DravetUK) 's Twitter Profile Photo

'The exercise helps with her very stiff limbs, mobility & is excellent for her mental health. Amy loves making the most of her pool membership, funded through the 16+ Assistance Fund. Thank you DSUK.' Glenys - Mum to Amy who lives with .

dravet.org.uk/apply-for-gran…

'The exercise helps with her very stiff limbs, mobility & is excellent for her mental health. Amy loves making the most of her pool membership, funded through the 16+ Assistance Fund. Thank you DSUK.' Glenys - Mum to Amy who lives with #DravetSyndrome. 

dravet.org.uk/apply-for-gran…
account_circle
CGTLive®(@CGT_Live) 's Twitter Profile Photo

It was found that at 3 months posttreatment, the 8 patients who received a single 70mg dose showed a mean 43% reduction from baseline in convulsive seizure frequency.

Syndrome Stoke Therapeutics

Read more:

cgtlive.com/view/stoke-the…

account_circle
Andreas Brunklaus(@a_brunklaus) 's Twitter Profile Photo

Looking forward to present at the meeting in Madrid 23 March . Sharing our recent advances in early diagnosis and impact on comorbidities.

Looking forward to present at the #DravetSyndrome meeting in Madrid 23 March #DSC2023. Sharing our recent advances in early diagnosis and impact on comorbidities.
account_circle
Epilepsia Hospital Ruber Internacional(@EpilepsiaHRuber) 's Twitter Profile Photo

DREXCO STUDY
A call to the Dravet syndrome community! We are conducting a very important study to better understand this condition. If you have a confirmed SCN1A mutation, your participation is crucial! Ruber Internacional

DREXCO STUDY
A call to the Dravet syndrome community! We are conducting a very important study to better understand this condition. If you have a confirmed SCN1A mutation, your participation is crucial!  #dravetsyndrome @RuberInter
account_circle
Stoke Therapeutics(@StokeTx) 's Twitter Profile Photo

The Stoke team gathered for , representing our ongoing support for epilepsy communities, including those living with and impacted by .

💜

The Stoke team gathered for #PurpleDay, representing our ongoing support for epilepsy communities, including those living with and impacted by #Dravetsyndrome.

#EpilepsyAwarenessDay 💜
account_circle
Dravet Syndrome UK(@DravetUK) 's Twitter Profile Photo

Families registered with us have the option to receive handwritten birthday cards, not only for their child/adult living with , but their siblings too.

'Each card is handwritten & addressed directly to them, making them feel special' - Rachael (Parent/Carer)

Families registered with us have the option to receive handwritten birthday cards, not only for their child/adult living with #DravetSyndrome, but their siblings too.

'Each card is handwritten & addressed directly to them, making them feel special' - Rachael (Parent/Carer)
account_circle
CGTLive®(@CGT_Live) 's Twitter Profile Photo

It was found that at 3 months posttreatment, the 8 patients who received a single 70mg dose showed a mean 43% reduction from baseline in convulsive seizure frequency.

Syndrome Stoke Therapeutics

Read more:

cgtlive.com/view/stoke-the…

account_circle